 Edward Hoffenberg
Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 29 | 2024 | 294 | 3.940 |
Why?
| | Crohn Disease | 11 | 2019 | 243 | 1.990 |
Why?
| | Inflammatory Bowel Diseases | 10 | 2022 | 351 | 1.840 |
Why?
| | Transglutaminases | 19 | 2024 | 156 | 1.490 |
Why?
| | Colitis, Ulcerative | 6 | 2019 | 136 | 1.490 |
Why?
| | Autoantibodies | 18 | 2024 | 1496 | 1.340 |
Why?
| | Marijuana Use | 2 | 2018 | 206 | 0.850 |
Why?
| | Medical Marijuana | 3 | 2019 | 117 | 0.700 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.620 |
Why?
| | Anti-Inflammatory Agents | 4 | 2017 | 496 | 0.600 |
Why?
| | Mass Screening | 6 | 2024 | 1287 | 0.560 |
Why?
| | Dronabinol | 1 | 2019 | 226 | 0.500 |
Why?
| | Arterio-Arterial Fistula | 1 | 2016 | 4 | 0.500 |
Why?
| | Hematemesis | 1 | 2016 | 3 | 0.500 |
Why?
| | Aneurysm, Infected | 1 | 2016 | 4 | 0.500 |
Why?
| | Esophageal Fistula | 1 | 2016 | 19 | 0.490 |
Why?
| | Intestinal Polyps | 2 | 2013 | 17 | 0.470 |
Why?
| | Aortic Coarctation | 1 | 2016 | 83 | 0.460 |
Why?
| | Marijuana Smoking | 1 | 2018 | 252 | 0.450 |
Why?
| | Health Services Misuse | 1 | 2014 | 33 | 0.440 |
Why?
| | Aortic Diseases | 1 | 2016 | 119 | 0.440 |
Why?
| | Capsule Endoscopy | 2 | 2013 | 18 | 0.410 |
Why?
| | Gastrointestinal Agents | 3 | 2017 | 65 | 0.410 |
Why?
| | Sertoli Cell Tumor | 1 | 2013 | 2 | 0.410 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 623 | 0.410 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2013 | 10 | 0.410 |
Why?
| | Motivation | 1 | 2018 | 570 | 0.410 |
Why?
| | Adolescent | 31 | 2024 | 21513 | 0.410 |
Why?
| | Antibodies, Monoclonal | 4 | 2014 | 1430 | 0.410 |
Why?
| | Intussusception | 1 | 2013 | 28 | 0.400 |
Why?
| | Child | 40 | 2024 | 21935 | 0.390 |
Why?
| | Short Bowel Syndrome | 3 | 2011 | 26 | 0.390 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 890 | 0.380 |
Why?
| | Immunoglobulin A | 8 | 2024 | 211 | 0.370 |
Why?
| | Cerebral Palsy | 1 | 2013 | 107 | 0.350 |
Why?
| | Jejunum | 1 | 2011 | 31 | 0.350 |
Why?
| | Gliadin | 2 | 2007 | 13 | 0.350 |
Why?
| | Heart Transplantation | 1 | 2017 | 754 | 0.350 |
Why?
| | Humans | 73 | 2024 | 137585 | 0.340 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 195 | 0.340 |
Why?
| | Pyloric Stenosis | 1 | 2010 | 2 | 0.330 |
Why?
| | Intestine, Small | 6 | 2013 | 156 | 0.330 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 97 | 0.330 |
Why?
| | Child, Preschool | 25 | 2024 | 11074 | 0.330 |
Why?
| | Autoimmunity | 4 | 2011 | 908 | 0.320 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2009 | 132 | 0.320 |
Why?
| | Jejunal Diseases | 1 | 2009 | 7 | 0.320 |
Why?
| | Ibuprofen | 1 | 2010 | 84 | 0.310 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3715 | 0.310 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 413 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1329 | 0.290 |
Why?
| | Infliximab | 4 | 2017 | 111 | 0.280 |
Why?
| | Male | 40 | 2024 | 67762 | 0.280 |
Why?
| | Colorado | 8 | 2024 | 4565 | 0.270 |
Why?
| | Wheat Hypersensitivity | 1 | 2007 | 4 | 0.270 |
Why?
| | Delivery of Health Care | 1 | 2014 | 951 | 0.270 |
Why?
| | Diet, Gluten-Free | 3 | 2024 | 45 | 0.260 |
Why?
| | Gastroenterology | 4 | 2023 | 180 | 0.260 |
Why?
| | Incidence | 5 | 2018 | 2804 | 0.260 |
Why?
| | Nutritional Support | 1 | 2006 | 34 | 0.250 |
Why?
| | Quality Improvement | 1 | 2014 | 1178 | 0.240 |
Why?
| | Female | 37 | 2024 | 73304 | 0.240 |
Why?
| | Enterocytes | 3 | 2003 | 16 | 0.230 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 40 | 0.230 |
Why?
| | HLA-DQ Antigens | 3 | 2017 | 181 | 0.230 |
Why?
| | Infant | 22 | 2024 | 9465 | 0.220 |
Why?
| | HLA-DR Antigens | 3 | 2017 | 228 | 0.220 |
Why?
| | Glutens | 5 | 2005 | 60 | 0.220 |
Why?
| | Antibodies, Fungal | 2 | 2005 | 9 | 0.220 |
Why?
| | Pregnancy Outcome | 1 | 2006 | 416 | 0.200 |
Why?
| | Citrulline | 1 | 2003 | 45 | 0.200 |
Why?
| | Case-Control Studies | 6 | 2019 | 3556 | 0.200 |
Why?
| | Time Factors | 7 | 2017 | 6828 | 0.200 |
Why?
| | Emergency Service, Hospital | 1 | 2014 | 2069 | 0.200 |
Why?
| | Antioxidants | 2 | 1997 | 584 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 5 | 2017 | 2426 | 0.190 |
Why?
| | Colonic Polyps | 2 | 2004 | 88 | 0.190 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2828 | 0.180 |
Why?
| | Home Care Services | 1 | 2005 | 257 | 0.180 |
Why?
| | Child Development | 1 | 2006 | 475 | 0.180 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 1946 | 0.180 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5131 | 0.180 |
Why?
| | Safety | 3 | 2017 | 338 | 0.170 |
Why?
| | Avena | 1 | 2000 | 4 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2006 | 527 | 0.170 |
Why?
| | Patient Satisfaction | 1 | 2005 | 660 | 0.170 |
Why?
| | Infant, Newborn | 10 | 2011 | 6079 | 0.160 |
Why?
| | Ileal Diseases | 2 | 2014 | 13 | 0.160 |
Why?
| | Abdominal Pain | 2 | 1999 | 145 | 0.160 |
Why?
| | Administration, Oral | 2 | 2019 | 816 | 0.160 |
Why?
| | Predictive Value of Tests | 4 | 2007 | 2031 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 2 | 2005 | 557 | 0.150 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 1999 | 36 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1242 | 0.150 |
Why?
| | Autoimmune Diseases | 3 | 2017 | 460 | 0.150 |
Why?
| | Government Regulation | 1 | 2019 | 54 | 0.150 |
Why?
| | Aminoglycosides | 1 | 2018 | 25 | 0.150 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5778 | 0.150 |
Why?
| | Diarrhea | 2 | 2018 | 184 | 0.150 |
Why?
| | Cannabinoids | 2 | 2017 | 161 | 0.150 |
Why?
| | Radioimmunoassay | 3 | 2005 | 173 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2018 | 73 | 0.140 |
Why?
| | Urine | 1 | 2017 | 59 | 0.140 |
Why?
| | Biopsy, Needle | 2 | 2011 | 189 | 0.130 |
Why?
| | Risk Factors | 8 | 2017 | 10388 | 0.130 |
Why?
| | Young Adult | 4 | 2019 | 13209 | 0.130 |
Why?
| | Prospective Studies | 6 | 2024 | 7604 | 0.130 |
Why?
| | Legislation, Drug | 1 | 2017 | 80 | 0.130 |
Why?
| | Feces | 3 | 2018 | 484 | 0.130 |
Why?
| | Endocannabinoids | 1 | 2017 | 63 | 0.130 |
Why?
| | Numismatics | 1 | 2015 | 1 | 0.120 |
Why?
| | Failure to Thrive | 1 | 1996 | 29 | 0.120 |
Why?
| | Colonoscopy | 2 | 2017 | 245 | 0.120 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 322 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 212 | 0.120 |
Why?
| | Retrospective Studies | 9 | 2023 | 15657 | 0.120 |
Why?
| | Case Management | 1 | 1996 | 66 | 0.120 |
Why?
| | Rotavirus Infections | 3 | 2006 | 43 | 0.120 |
Why?
| | Duodenum | 4 | 2022 | 78 | 0.120 |
Why?
| | Serologic Tests | 3 | 2007 | 54 | 0.120 |
Why?
| | Alagille Syndrome | 1 | 1995 | 33 | 0.120 |
Why?
| | Quality of Health Care | 2 | 2018 | 642 | 0.110 |
Why?
| | Critical Pathways | 1 | 1996 | 96 | 0.110 |
Why?
| | After-Hours Care | 1 | 2014 | 15 | 0.110 |
Why?
| | Biological Products | 1 | 2018 | 216 | 0.110 |
Why?
| | Pneumococcal Infections | 1 | 2016 | 115 | 0.110 |
Why?
| | Foreign Bodies | 1 | 2015 | 104 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5472 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 532 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 852 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 2016 | 169 | 0.110 |
Why?
| | Prevalence | 3 | 2013 | 2734 | 0.110 |
Why?
| | Colitis | 1 | 2017 | 266 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 1996 | 209 | 0.110 |
Why?
| | Telemedicine | 1 | 2023 | 862 | 0.110 |
Why?
| | Quality of Life | 3 | 2024 | 2892 | 0.100 |
Why?
| | Rotavirus | 4 | 2006 | 20 | 0.100 |
Why?
| | Self Report | 1 | 2018 | 827 | 0.100 |
Why?
| | Esophagus | 1 | 2015 | 255 | 0.100 |
Why?
| | Biopsy | 3 | 2007 | 1129 | 0.100 |
Why?
| | Rectal Fistula | 1 | 2013 | 28 | 0.100 |
Why?
| | Age Factors | 3 | 2013 | 3295 | 0.100 |
Why?
| | Sertoli Cells | 1 | 2013 | 26 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 622 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 142 | 0.100 |
Why?
| | Treatment Outcome | 6 | 2018 | 10811 | 0.100 |
Why?
| | Laparoscopy | 1 | 1997 | 466 | 0.100 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 786 | 0.100 |
Why?
| | Pigmentation | 1 | 2013 | 52 | 0.100 |
Why?
| | Stomach | 1 | 2013 | 110 | 0.100 |
Why?
| | Cholestasis | 1 | 1995 | 235 | 0.100 |
Why?
| | Colon | 2 | 2013 | 282 | 0.090 |
Why?
| | Receptors, Virus | 1 | 2011 | 83 | 0.090 |
Why?
| | Microvilli | 2 | 2001 | 78 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 518 | 0.090 |
Why?
| | Cystic Fibrosis | 2 | 2015 | 1114 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 398 | 0.090 |
Why?
| | Risk Assessment | 2 | 2011 | 3457 | 0.080 |
Why?
| | GTP-Binding Proteins | 2 | 2024 | 161 | 0.080 |
Why?
| | Plant Proteins | 1 | 2011 | 113 | 0.080 |
Why?
| | Food Hypersensitivity | 2 | 2004 | 183 | 0.080 |
Why?
| | Age Distribution | 1 | 2011 | 392 | 0.080 |
Why?
| | Sex Distribution | 1 | 2011 | 375 | 0.080 |
Why?
| | Mutation, Missense | 1 | 2011 | 341 | 0.080 |
Why?
| | Hospitals, Pediatric | 1 | 2013 | 508 | 0.080 |
Why?
| | Cytomegalovirus Infections | 2 | 2001 | 192 | 0.080 |
Why?
| | Statistics, Nonparametric | 2 | 2000 | 431 | 0.080 |
Why?
| | Prednisolone | 1 | 2009 | 83 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 816 | 0.080 |
Why?
| | Diagnosis, Differential | 2 | 2007 | 1483 | 0.080 |
Why?
| | Antibodies | 1 | 2011 | 410 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1738 | 0.070 |
Why?
| | Practice Guidelines as Topic | 3 | 2023 | 1587 | 0.070 |
Why?
| | Family | 1 | 2013 | 671 | 0.070 |
Why?
| | Antibodies, Viral | 3 | 2006 | 625 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1809 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 113 | 0.070 |
Why?
| | Liver Transplantation | 1 | 1995 | 871 | 0.070 |
Why?
| | Prognosis | 3 | 2019 | 4030 | 0.070 |
Why?
| | Cost-Benefit Analysis | 2 | 2014 | 591 | 0.070 |
Why?
| | Cafe-au-Lait Spots | 1 | 2007 | 4 | 0.070 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2009 | 228 | 0.070 |
Why?
| | Self-Help Groups | 1 | 2007 | 35 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 697 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 2071 | 0.070 |
Why?
| | Adult | 7 | 2019 | 37929 | 0.060 |
Why?
| | Disease Progression | 1 | 2014 | 2757 | 0.060 |
Why?
| | Cisapride | 1 | 2006 | 5 | 0.060 |
Why?
| | Apgar Score | 1 | 2006 | 17 | 0.060 |
Why?
| | Liver Cirrhosis | 2 | 2015 | 316 | 0.060 |
Why?
| | Edible Grain | 1 | 2005 | 49 | 0.060 |
Why?
| | Infant, Low Birth Weight | 1 | 2006 | 141 | 0.060 |
Why?
| | Mycoses | 1 | 2005 | 79 | 0.060 |
Why?
| | Infant, Newborn, Diseases | 1 | 2006 | 113 | 0.060 |
Why?
| | Child Nutrition Disorders | 1 | 2004 | 20 | 0.060 |
Why?
| | Societies, Medical | 4 | 2018 | 820 | 0.060 |
Why?
| | Growth | 1 | 2004 | 60 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 158 | 0.050 |
Why?
| | Adenomatous Polyposis Coli | 2 | 2007 | 39 | 0.050 |
Why?
| | Catheterization | 2 | 2001 | 179 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2004 | 92 | 0.050 |
Why?
| | Genetic Testing | 1 | 2007 | 460 | 0.050 |
Why?
| | Peptide Fragments | 1 | 2007 | 706 | 0.050 |
Why?
| | Atrophy | 1 | 2003 | 184 | 0.050 |
Why?
| | Research | 2 | 2004 | 451 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 398 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 1993 | 137 | 0.050 |
Why?
| | Paracentesis | 1 | 2001 | 14 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 581 | 0.050 |
Why?
| | Colonic Diseases | 1 | 2001 | 33 | 0.050 |
Why?
| | Ascites | 1 | 2001 | 46 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2002 | 43 | 0.040 |
Why?
| | Infant, Premature | 1 | 2006 | 574 | 0.040 |
Why?
| | North America | 2 | 2018 | 313 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 740 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2000 | 148 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2057 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2006 | 2844 | 0.040 |
Why?
| | Cohort Studies | 2 | 2003 | 5742 | 0.040 |
Why?
| | Genes, p53 | 1 | 1999 | 72 | 0.040 |
Why?
| | Genes, ras | 1 | 1999 | 97 | 0.040 |
Why?
| | Aneuploidy | 1 | 1999 | 89 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2004 | 1096 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2007 | 1996 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1627 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 23 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 691 | 0.040 |
Why?
| | Placebo Effect | 1 | 1997 | 25 | 0.030 |
Why?
| | Limit of Detection | 1 | 2017 | 85 | 0.030 |
Why?
| | Anemia | 1 | 1999 | 170 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 1997 | 43 | 0.030 |
Why?
| | Receptors, Cannabinoid | 1 | 2017 | 15 | 0.030 |
Why?
| | Diet | 1 | 2005 | 1278 | 0.030 |
Why?
| | Hospital Costs | 1 | 1997 | 117 | 0.030 |
Why?
| | Vitamin E | 1 | 1997 | 124 | 0.030 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 1996 | 22 | 0.030 |
Why?
| | Biomarkers | 2 | 2009 | 4149 | 0.030 |
Why?
| | Homozygote | 2 | 2011 | 203 | 0.030 |
Why?
| | Nursing Audit | 1 | 1996 | 6 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1996 | 88 | 0.030 |
Why?
| | Pediatric Nursing | 1 | 1996 | 42 | 0.030 |
Why?
| | Models, Nursing | 1 | 1996 | 37 | 0.030 |
Why?
| | Free Radicals | 1 | 1996 | 110 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 1996 | 153 | 0.030 |
Why?
| | Ascorbic Acid | 1 | 1997 | 177 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1995 | 46 | 0.030 |
Why?
| | Body Mass Index | 1 | 2004 | 2389 | 0.030 |
Why?
| | Phagocytes | 1 | 1996 | 101 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 597 | 0.030 |
Why?
| | Glutathione | 1 | 1997 | 356 | 0.030 |
Why?
| | Radioligand Assay | 2 | 2009 | 48 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 628 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 161 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5647 | 0.030 |
Why?
| | Biliary Atresia | 1 | 1996 | 163 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2014 | 30 | 0.030 |
Why?
| | HLA Antigens | 2 | 2006 | 240 | 0.030 |
Why?
| | Pregnancy | 2 | 2006 | 6763 | 0.030 |
Why?
| | Child Health Services | 1 | 2016 | 184 | 0.030 |
Why?
| | Nurse Practitioners | 1 | 1996 | 138 | 0.030 |
Why?
| | Gene Expression | 1 | 1999 | 1502 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 106 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2199 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 1998 | 655 | 0.020 |
Why?
| | Child Nutritional Physiological Phenomena | 2 | 2004 | 108 | 0.020 |
Why?
| | Animals | 4 | 2017 | 36940 | 0.020 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2011 | 7 | 0.020 |
Why?
| | Survival Analysis | 1 | 1995 | 1325 | 0.020 |
Why?
| | Cricetulus | 1 | 2011 | 109 | 0.020 |
Why?
| | CHO Cells | 1 | 2011 | 161 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1916 | 0.020 |
Why?
| | Vacuoles | 2 | 2001 | 40 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 289 | 0.020 |
Why?
| | Heterozygote | 1 | 2011 | 293 | 0.020 |
Why?
| | Morphogenesis | 1 | 2011 | 166 | 0.020 |
Why?
| | Survival Rate | 1 | 1995 | 1972 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 956 | 0.020 |
Why?
| | Transfection | 1 | 2011 | 945 | 0.020 |
Why?
| | Thinness | 1 | 2009 | 91 | 0.020 |
Why?
| | Methyltransferases | 1 | 2009 | 78 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 288 | 0.020 |
Why?
| | International Cooperation | 1 | 2009 | 198 | 0.020 |
Why?
| | Biomedical Research | 1 | 2014 | 692 | 0.020 |
Why?
| | Mutation | 1 | 1999 | 3958 | 0.020 |
Why?
| | Zebrafish | 1 | 2011 | 499 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 554 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 860 | 0.020 |
Why?
| | Tuberculosis | 1 | 2009 | 279 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1101 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2837 | 0.020 |
Why?
| | Iodide Peroxidase | 1 | 2005 | 28 | 0.010 |
Why?
| | Thyroglobulin | 1 | 2005 | 27 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 2005 | 165 | 0.010 |
Why?
| | Genes, APC | 1 | 2004 | 12 | 0.010 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2004 | 20 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2005 | 189 | 0.010 |
Why?
| | Loss of Heterozygosity | 1 | 2004 | 51 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 305 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2189 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3196 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1993 | 75 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 253 | 0.010 |
Why?
| | Malabsorption Syndromes | 1 | 2002 | 16 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 480 | 0.010 |
Why?
| | Plasma Volume | 1 | 2001 | 19 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1864 | 0.010 |
Why?
| | Punctures | 1 | 2001 | 40 | 0.010 |
Why?
| | Gastroschisis | 1 | 2001 | 29 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 891 | 0.010 |
Why?
| | Needles | 1 | 2001 | 59 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4295 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2001 | 153 | 0.010 |
Why?
| | Immunity, Cellular | 2 | 1993 | 268 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2005 | 893 | 0.010 |
Why?
| | United States | 1 | 2018 | 14841 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 443 | 0.010 |
Why?
| | Drainage | 1 | 2001 | 173 | 0.010 |
Why?
| | Mice | 1 | 2017 | 17787 | 0.010 |
Why?
| | Family Relations | 1 | 1998 | 91 | 0.010 |
Why?
| | Autoradiography | 1 | 1996 | 78 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1996 | 34 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 282 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1062 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2181 | 0.010 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.010 |
Why?
| | RNA, Viral | 1 | 1996 | 656 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 33479 | 0.010 |
Why?
| | Antibody Formation | 1 | 1993 | 298 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2900 | 0.010 |
Why?
| | Acute Disease | 1 | 1993 | 1007 | 0.010 |
Why?
| | Fetal Blood | 1 | 1992 | 327 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2001 | 2654 | 0.000 |
Why?
| | Lymphocyte Activation | 1 | 1992 | 1142 | 0.000 |
Why?
| | Cell Line | 1 | 1993 | 2847 | 0.000 |
Why?
| | HIV Infections | 1 | 2002 | 2836 | 0.000 |
Why?
| | Aged | 1 | 1999 | 23961 | 0.000 |
Why?
|
|
Hoffenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|